Unknown

Dataset Information

0

Non-adherence to anti-tuberculosis treatment, reasons and associated factors among TB patients attending at Gondar town health centers, Northwest Ethiopia.


ABSTRACT: OBJECTIVE:The aim of this study was to assess the prevalence of non-adherence to anti-tuberculosis treatment, reasons and associated factors among TB patients attending at Gondar town health centers. RESULT:A total of 314 participants were included with the response rate of 97.5%. The mean age of participants was 35.94 (SD?±?13.83) years. The overall rate of non-adherence to anti-TB treatment was 21.2% (95% CI 17.2, 26.1). Continuation phase of treatment (AOR?=?2.27, 95% CI (1.54, 5.94)), presence of more than one co-morbidity (AOR?=?6.22; 95% CI (2.21, 17.48)), poor knowledge about TB and anti-TB therapy (AOR?=?4.11; 95% CI 1.57, 10.75), poor patient-provider relationship (AOR?=?4.60, 95% CI 1.63, 12.97), and alcohol intake (AOR?=?5.03; 95% CI 1.54, 16.40) were significantly associated with non-adherence. Forgetting 40 (23.1%), Being busy with other work 35 (20.2%), and being out of home/town 24 (13.9%) were the major reasons of participants for interruption of taking anti-TB medications.

SUBMITTER: Mekonnen HS 

PROVIDER: S-EPMC6167840 | biostudies-other | 2018 Oct

REPOSITORIES: biostudies-other

altmetric image

Publications

Non-adherence to anti-tuberculosis treatment, reasons and associated factors among TB patients attending at Gondar town health centers, Northwest Ethiopia.

Mekonnen Habtamu Sewunet HS   Azagew Abere Woretaw AW  

BMC research notes 20181001 1


<h4>Objective</h4>The aim of this study was to assess the prevalence of non-adherence to anti-tuberculosis treatment, reasons and associated factors among TB patients attending at Gondar town health centers.<h4>Result</h4>A total of 314 participants were included with the response rate of 97.5%. The mean age of participants was 35.94 (SD ± 13.83) years. The overall rate of non-adherence to anti-TB treatment was 21.2% (95% CI 17.2, 26.1). Continuation phase of treatment (AOR = 2.27, 95% CI (1.54,  ...[more]

Similar Datasets

| S-EPMC6743162 | biostudies-literature
| S-EPMC7197001 | biostudies-literature
| S-EPMC6476509 | biostudies-literature
| S-EPMC6478322 | biostudies-literature
| S-EPMC5603327 | biostudies-literature
| S-EPMC8496848 | biostudies-literature
| S-EPMC8248645 | biostudies-literature
| S-EPMC6098601 | biostudies-literature
| S-EPMC6591879 | biostudies-other
| S-EPMC6425615 | biostudies-literature